JOINT FILING AGREEMENT
Exhibit 99.1
The undersigned hereby agree that the statement on Schedule 13G, dated February 5, 2021 (the “Schedule 13G”), with respect to the common stock, par value $0.01 per share, of Beam Therapeutics Inc. is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment.
Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned hereby execute this Joint Filing Agreement as of the 5th day of February, 2021.
| Dated: February 5, 2021 | TEMASEK HOLDINGS (PRIVATE) LIMITED | |||||||
| By: | /s/ Xxxxxx Xxx Lye Whatt | |||||||
| Name | : | Xxxxxx Xxx Lye Whatt | ||||||
| Title | : | Authorized Signatory | ||||||
| Dated: February 5, 2021 | FULLERTON MANAGEMENT PTE LTD | |||||||
| By: | /s/ Xxxxxxx Xxx | |||||||
| Name | : | Xxxxxxx Xxx | ||||||
| Title | : | Director | ||||||
| Dated: February 5, 2021 | TEMASEK LIFE SCIENCES PRIVATE LIMITED | |||||||
| By: | /s/ Xxx Xxxx Xxx Xxxxxxx | |||||||
| Name | : | Xxx Xxxx Xxx Xxxxxxx | ||||||
| Title | : | Director | ||||||
| Dated: February 5, 2021 | TLS BETA PTE. LTD. | |||||||
| By: | /s/ Zahedah Xxxxx Xxxxxx | |||||||
| Name | : | Zahedah Xxxxx Xxxxxx | ||||||
| Title | : | Director | ||||||
